Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004).
Masanori Toyoda
No relevant relationships to disclose
Tetsuo Ajiki
No relevant relationships to disclose
Yutaka Fujiwara
No relevant relationships to disclose
Hiroaki Nagano
No relevant relationships to disclose
Shogo Kobayashi
No relevant relationships to disclose
Daisuke Sakai
No relevant relationships to disclose
Etsuro Hatano
No relevant relationships to disclose
Masashi Kanai
No relevant relationships to disclose
Shoji Nakamori
No relevant relationships to disclose
Atsushi Miyamoto
No relevant relationships to disclose
Akihito Tsuji
Other Remuneration - Taiho Pharmaceutical
Satoshi Kaihara
No relevant relationships to disclose
Hisashi Ikoma
No relevant relationships to disclose
Shigekazu Takemura
No relevant relationships to disclose
Hideyoshi Toyokawa
No relevant relationships to disclose
Hiroaki Terajima
No relevant relationships to disclose
Tatsuya Ioka
Research Funding - Yakult Honsha